News
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
Wall Street held near its record heights on Monday, ahead of a week likely to be dominated by updates from the head of the ...
Novo Nordisk (NYSE:NVO) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On August 15, Novo ...
The clinical-stage biotech, closely watched by some because of its investigational weight-loss drug VK2735, saw its share ...
Dow Jones Top Company Headlines at 9 PM ET: SoftBank Invests $2 Billion in Intel as U.S. Considers Taking 10% Stake in Chip Maker | BHP ... SoftBank Invests $2 Billion in Intel as U.S. Considers ...
The detention facility operator named Patrick Swindle as its next chief executive officer, succeeding long-time executive Damon Hininger, who will continue at the company under a transition agreement.
Worldwide, 3·9 million individuals have kidney failure requiring maintenance dialysis.1,2 Considerable resources—more than 7% ...
I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...
U.S. District Judge Karen Marston, of the Eastern District of Pennsylvania, allowed some misrepresentation claims to go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results